Drug Test/Screening Collector Training & Certification, Wakefield, PA

For

Collection Sites, Medical Facilities, DER's, HR Managers, Safety Managers, Court Personnel, Probation Officers, TPA's

Accredited Drug Testing provides a comprehensive online/web-based Urine Drug Testing Collector Training and Certification course in Wakefield, PA for persons required as part of their responsibilities to perform or supervise urine drug testing specimen collections. The collector training program may be completed with or without the required mock collection proficiency assessments. Upon completion of the training program, students will receive a certificate of successful completion of the training course. In Wakefield, PA to be qualified/certified as a DOT urine drug test collector, you must satisfactorily complete both the training course and a minimum of 5 error free proficiency mock demonstrations.

Collector Training Only

(800) 221-4291

Training & Proficiency Demonstrations

The Drug Test Collector plays a critical role in the workplace drug screening process. Along with the employer, the testing facility and the Medical Review Officer (MRO), the collector is an essential part of a system developed to ensure drug-free workplaces for the sake of public safety.

As the collector, you are the only individual in the drug-testing process who has direct, face-to-face contact with the employee. You ensure the integrity of the urine specimen and collection process and begin the chain of custody that includes the laboratory; the MRO; the employer; and, possibly, the courts.

This training is a professional-level course that provides the knowledge and skills to qualify Drug Test Collectors to perform U.S. Department of Transportation-regulated drug tests and non-regulated tests. Course participants also have the option of becoming professionally certified after completion of this course. This designation confirms that the collector is committed to the highest standards in the drug and alcohol testing industry.

The Course

This professional-level course meets the regulatory standards of U.S. Department of Transportation (DOT) rule 49 CFR Part 40 and provides a solid foundation for a wide range of testing programs.

Library of terms & resources
Universal skills set
Multiple industries
Lessons
DOT Qualification
Public sector
Short quizzes & final examination
Professional Certification
Private sector
Mock collections
Regulated by local, state and federal authorities
Signature

How to become a DOT Qualified Urine Colletor?

To become qualified as a collector, you must be knowledgeable about Part 40 regulations, the current "DOT Urine Specimen Collection Procedures Guidelines," and DOT agency regulations applicable to the employers for whom you will perform collections, and you must keep current on any changes to these materials. You must also (1) successfully complete a qualification training program and (2) pass a monitored proficiency demonstration, as required by DOT regulations [See 49 CFR Part 40.33 (b-c), effective August 1, 2001]. Please note: there is no "grandfather" clause or waiver from this requirement. A collector's qualifications are not location/collection site specific, and their eligibility will follow them anywhere DOT Agency regulated urine specimens are collected. There is no requirement for qualified collectors to register or to be on any federally-maintained or federally-sponsored list, but they are required to maintain (for Federal inspection) documentation of successful completion of their training and proficiency demonstration requirements.

How to Take the Course

The Drug Test Collector Training involves multiple parts that need to be completed in a specific order to achieve certification.

Before starting the training, the collector must:
- review 49 CFR Part 40 and be familiar with the regulatory language;
- review the DOT Urine Specimen Collection Guidelines;
- review "Instructions for Completing the Federal Drug Testing Custody and Control Form for Urine Specimen Collection"
- watch DOT's 10 Steps to Collection Site Security and Integrity video.
- and download the sample Custody and Control Form. This form guides the entire drug-collection process. Review the document and have it at hand through the entire course. (All required materials are also available in the Reference Library.) NOTE: The 2017 version of the CCF is no longer current. If you intend to use it, you must attach a Memorandum for Record (MFR).
Take the course Pre-Test to show familiarity with the subject matter based on a review of the materials provided.
Complete the lessons of the training along with the required short quizzes.
Take the final exam. A score of at least 90 percent is required.
When you pass the online portion of this training, continue to the Next Steps lesson for instructions on how to set up five mock collections with a live examiner. These must be scheduled within 30 days of course completion and are required for qualification and certification.
Once the mock collections are completed without error, you will be qualified and can perform both federally regulated and non-regulated drug test collections.
To be certified, qualified collectors are asked to sign an agreement promising to adhere to the standards set in the training. The course administrator will then issue a certification form documenting that the collector is both a USDOT Qualified and Professionally Certified Drug Testing Collector. Contact the course administrator for more information.

Collector Training Only

(800) 221-4291

Wakefield, PA Drug Testing

Wakefield, PA Certified Drug Test Collector Training

Wakefield, PA FMCSA Drug Testing

Wakefield, PA Drug Test Locations

Wakefield, PA Lab and Blood Testing

Wakefield, PA STD Testing

Wakefield, PA In-Home Drug Testing

Wakefield, PA DNA Testing

Local Area Info: Andrew Wakefield

Andrew Jeremy Wakefield (born 1957) is a discredited former British doctor who became an anti-vaccine activist. He was a gastroenterologist until he was struck off the UK medical register for unethical behaviour, misconduct and dishonesty for authoring a fraudulent research paper that claimed a link between the measles, mumps and rubella (MMR) vaccine and autism and bowel disease.

After the publication of the paper, other researchers were unable to reproduce Wakefield's findings or confirm his hypothesis of an association between the MMR vaccine and autism, or autism and gastrointestinal disease. A 2004 investigation by Sunday Times reporter Brian Deer identified undisclosed financial conflicts of interest on Wakefield's part, and most of his co-authors then withdrew their support for the study's interpretations. The British General Medical Council (GMC) conducted an inquiry into allegations of misconduct against Wakefield and two former colleagues. The investigation centred on Deer's numerous findings, including that children with autism were subjected to unnecessary invasive medical procedures such as colonoscopies and lumbar punctures, and that Wakefield acted without the required ethical approval from an institutional review board.

On 28 January 2010, a five-member statutory tribunal of the GMC found three dozen charges proved, including four counts of dishonesty and 12 counts involving the abuse of developmentally delayed children. The panel ruled that Wakefield had "failed in his duties as a responsible consultant", acted both against the interests of his patients, and "dishonestly and irresponsibly" in his published research. The Lancet fully retracted the 1998 publication on the basis of the GMC's findings, noting that elements of the manuscript had been falsified. The Lancet's editor-in-chief Richard Horton said the paper was "utterly false" and that the journal had been "deceived". Three months following The Lancet's retraction, Wakefield was struck off the UK medical register, with a statement identifying deliberate falsification in the research published in The Lancet, and was thereby barred from practising medicine in the UK. A British Administrative Court Justice noted in a related decision—"There is now no respectable body of opinion which supports (Dr. Wakefield's) hypothesis, that MMR vaccine and autism/enterocolitis are causally linked".